Versant Venture Management’s Aligos Therapeutics ALGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-58,317
Closed -$510K 7
2024
Q2
$510K Sell
58,317
-34,498
-37% -$607K 0.66% 8
2024
Q1
$2.27M Hold
92,815
2.2% 7
2023
Q4
$1.54M Hold
92,815
0.4% 7
2023
Q3
$1.73M Hold
92,815
0.92% 7
2023
Q2
$2.25M Hold
92,815
2.67% 7
2023
Q1
$2.03M Hold
92,815
4.23% 6
2022
Q4
$2.21M Hold
92,815
4.58% 6
2022
Q3
$2.55M Hold
92,815
4.35% 5
2022
Q2
$2.81M Hold
92,815
4.3% 6
2022
Q1
$4.99M Hold
92,815
4.98% 8
2021
Q4
$27.5M Hold
92,815
14.73% 4
2021
Q3
$36M Hold
92,815
14.9% 4
2021
Q2
$47.3M Sell
92,815
-38,879
-30% -$24.8M 15.67% 3
2021
Q1
$74.9M Hold
131,694
14.59% 3
2020
Q4
$91M Buy
+131,694
New +$64.1M 9.45% 3

Other funds holding ALGS